DK1334123T3 - Eukaryotiske celledelingsgener og deres anvendelse til diagnose og behandling af proliferative sygdomme - Google Patents

Eukaryotiske celledelingsgener og deres anvendelse til diagnose og behandling af proliferative sygdomme

Info

Publication number
DK1334123T3
DK1334123T3 DK01993708T DK01993708T DK1334123T3 DK 1334123 T3 DK1334123 T3 DK 1334123T3 DK 01993708 T DK01993708 T DK 01993708T DK 01993708 T DK01993708 T DK 01993708T DK 1334123 T3 DK1334123 T3 DK 1334123T3
Authority
DK
Denmark
Prior art keywords
diagnosis
treatment
cell division
proliferative diseases
eukaryotic cell
Prior art date
Application number
DK01993708T
Other languages
Danish (da)
English (en)
Inventor
Pierre Goenczy
Steven Jones
Christophe Echeverri
Anthony Hyman
Karen Oegema
Matthew Kirkham
Original Assignee
Cenix Bioscience Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenix Bioscience Gmbh filed Critical Cenix Bioscience Gmbh
Application granted granted Critical
Publication of DK1334123T3 publication Critical patent/DK1334123T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C07K14/43545Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK01993708T 2000-11-09 2001-11-09 Eukaryotiske celledelingsgener og deres anvendelse til diagnose og behandling af proliferative sygdomme DK1334123T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24675000P 2000-11-09 2000-11-09
PCT/EP2001/013034 WO2002038805A2 (en) 2000-11-09 2001-11-09 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases

Publications (1)

Publication Number Publication Date
DK1334123T3 true DK1334123T3 (da) 2009-01-12

Family

ID=22932039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01993708T DK1334123T3 (da) 2000-11-09 2001-11-09 Eukaryotiske celledelingsgener og deres anvendelse til diagnose og behandling af proliferative sygdomme

Country Status (9)

Country Link
US (1) US7368248B2 (https=)
EP (1) EP1334123B1 (https=)
JP (1) JP2004526421A (https=)
AT (1) ATE405585T1 (https=)
AU (2) AU2002224838B9 (https=)
CA (1) CA2428438C (https=)
DE (1) DE60135482D1 (https=)
DK (1) DK1334123T3 (https=)
WO (1) WO2002038805A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8202979B2 (en) 2002-02-20 2012-06-19 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
WO2003070918A2 (en) 2002-02-20 2003-08-28 Ribozyme Pharmaceuticals, Incorporated Rna interference by modified short interfering nucleic acid
US7517864B2 (en) 2001-05-18 2009-04-14 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US9994853B2 (en) 2001-05-18 2018-06-12 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
WO2005078097A2 (en) 2004-02-10 2005-08-25 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (Multifunctional siNA)
US20050148530A1 (en) 2002-02-20 2005-07-07 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US9657294B2 (en) 2002-02-20 2017-05-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
AU2003207708A1 (en) 2002-02-20 2003-09-09 Sirna Therapeutics, Inc. Rna interference mediated inhibition of map kinase genes
US9181551B2 (en) 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
WO2005049846A2 (en) * 2003-11-17 2005-06-02 Crusade Laboratories Limited Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer
AU2005238034A1 (en) 2004-04-23 2005-11-10 The Trustees Of Columbia University In The City Of New York Inhibition of hairless protein mRNA
US10508277B2 (en) 2004-05-24 2019-12-17 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
EP2980220A1 (en) 2005-09-20 2016-02-03 BASF Plant Science GmbH Improved methods controlling gene expression
PL2129680T3 (pl) 2007-03-21 2015-10-30 Brookhaven Science Ass Llc Łączone kompozycje cząsteczek antysensownych o strukturze spinki do włosów oraz sposoby modulacji ekspresji
EP3000885B1 (en) 2009-12-18 2018-07-25 Arrowhead Pharmaceuticals, Inc. Organic compositions to treat hsf1-related diseases
JP2013519869A (ja) 2010-02-10 2013-05-30 ノバルティス アーゲー 筋肉成長のための方法および化合物
WO2012058210A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910962D0 (en) 1989-05-12 1989-06-28 Natural Environment Res Novel baculovirus expression vectors and use thereof in the expression of foreign proteins in insects or insect cells
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
US5155037A (en) 1989-08-04 1992-10-13 The Texas A&M University System Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins

Also Published As

Publication number Publication date
CA2428438A1 (en) 2002-05-16
US7368248B2 (en) 2008-05-06
AU2002224838B2 (en) 2006-07-27
WO2002038805A8 (en) 2007-07-05
ATE405585T1 (de) 2008-09-15
WO2002038805A3 (en) 2003-02-13
DE60135482D1 (de) 2008-10-02
US20040048277A1 (en) 2004-03-11
JP2004526421A (ja) 2004-09-02
AU2002224838B9 (en) 2007-02-08
CA2428438C (en) 2012-09-25
AU2483802A (en) 2002-05-21
EP1334123A2 (en) 2003-08-13
WO2002038805A2 (en) 2002-05-16
EP1334123B1 (en) 2008-08-20

Similar Documents

Publication Publication Date Title
DK1334123T3 (da) Eukaryotiske celledelingsgener og deres anvendelse til diagnose og behandling af proliferative sygdomme
IL258880A (en) Diarylhydantoin compounds
NO20055731L (no) Cannabinoide reseptorligander og deres anvendelse
TR200302309T4 (tr) Fosfodiesterazın yararlı inhibitörleri olarak beta-karbolin türevleri.
BR0011838B1 (pt) elemento de sela e estrutura de misturador estático.
NO20081212L (no) Xantinderivater som selektive HM74A agonister
BRPI0607306A2 (pt) derivados de quinoxalina como agentes anti-tumor
ATE415397T1 (de) Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen
BR0107943A (pt) Sìtios de entrada de ribossoma internos sintéticos e métodos de identificar os mesmos
NO20055516L (no) Kannabinoidreceptorligander og anvendelser derav
DE602007012261D1 (de) Triazolyl-pyridyl-benzolsulfonamide als ccr2- oder ccr9-modulatoren zur behandlung von atherosklerose
DE602004029904D1 (de) Neue tricyclische nukleoside oder nukleotide als therapeutische mittel
NO20052928L (no) Nye kjemiske forbindelser
NO20052512L (no) Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander
ATE411805T1 (de) Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
MY142988A (en) Novel aminobenzophenone compounds
EP1611120A4 (en) NEW METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
EA200500934A1 (ru) Соединения, модулирующие активность киназного белка множественных линий, и способы лечения нейродегенеративных и воспалительных заболеваний
WO2002090925A3 (en) Polypeptides and nucleic acids associated with cancer
MA32224B1 (fr) Derives de (pyrazolyl-carbonyl) imidazolidinone pour le traitement de maladies retrovirales
EP1824498A4 (en) METHOD AND COMPOSITIONS FOR TREATING PROLIFERATIVE CELL DISEASES
EP1768679A4 (en) MODULATION OF GSK-3B AND METHOD FOR THE TREATMENT OF PROLIFERATIVE DISEASES
ATE397000T1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs